Medtronic Announces New StealthStation(TM) Technology for Ear, Nose, and Throat Procedures
September 12 2017 - 8:00AM
YASTEST
New Platform to
Offer Enhanced Visualization and Increased Efficiency for Surgery
of the Sinuses and Skull Base
DUBLIN - September 12, 2017 -
Medtronic plc (NYSE: MDT) today announced the global launch of the
StealthStation(TM) ENT, a new surgical navigation system designed
for surgeons treating conditions within the ear, nose, and throat
(ENT) anatomy. The company has received U.S. Food and Drug
Administration 510k clearance and CE (Conformité Européenne) Mark
for the system.
StealthStation ENT uses a proprietary
electromagnetic (EM) tracking technology. It works by generating an
electromagnetic field around the target patient anatomy during
surgery so that instrument positioning is dynamically tracked
throughout a procedure, similar to a GPS system for cars.
"The intraoperative use of computer-aided surgery
is very helpful to assist the surgeon in clarifying complex anatomy
during sinus and skull base surgery," said Joseph Raviv, M.D.,
director of Endoscopic Sinus and Skull Base Surgery at NorthShore
University HealthSystem in Chicago. "It provides an added level of
assurance and may allow for a more thorough sinus procedure."
The StealthStation ENT system provides enhanced
visualization to surgeons and also offers new software and hardware
innovations including Virtual Endoscopy, which provides a simulated
view of sinus cavities previously inaccessible with a traditional
endoscope. Virtual Endoscopy can be loaded with the patient's
preoperative data to allow the surgeon to practice an individual's
surgery before he or she enters the surgical suite.
"Our goal is to improve outcomes for ENT patients
by delivering innovative, market-leading products and solutions,"
said Vince Racano, vice president and general manager of
Medtronic's ENT business unit, which is part of the Restorative
Therapies Group. "StealthStation ENT is one of the ways Medtronic
continues to expand the boundaries of what's possible with ENT
navigation."
To support operating room efficiency,
StealthStation ENT features include an emitter that can be placed
under the patient's head - allowing more space for personnel around
the table - and a 27-inch, high-resolution touchscreen with an
intuitive user interface that can be tailored by the surgeon.
|
|
StealthStation(TM) ENT |
StealthStation(TM) ENT - Touchscreen |
Click the thumbnails above for a larger image. |
About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin,
Ireland, is among the world's largest medical technology, services
and solutions companies - alleviating pain, restoring health and
extending life for millions of people around the world. Medtronic
employs more than 84,000 people worldwide, serving physicians,
hospitals and patients in approximately 160 countries. The company
is focused on collaborating with stakeholders around the world to
take healthcare Further, Together.
Any forward-looking statements
are subject to risks and uncertainties such as those described in
Medtronic's periodic reports on file with the Securities and
Exchange Commission. Actual results may differ materially from
anticipated results.
-end-
Contacts:
Candy Bowen
Public Relations
+1-904-332-8163
Ryan Weispfenning
Investor Relations
+1-763-505-4626
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Medtronic plc via Globenewswire
Medtronic (NYSE:MDT)
Historical Stock Chart
From Apr 2024 to May 2024
Medtronic (NYSE:MDT)
Historical Stock Chart
From May 2023 to May 2024